SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Common Stock Repurchased

Cash spent buying back the company's own shares.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Common Stock Repurchased · Q1 FY2026 · quarter ended Mar 2026

Common stock repurchased of $0 in Q1 FY2026

Q1 FY2026 common stock repurchased was $0.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
-$1.45M— YoY
Common Stock Repurchased past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Common Stock Repurchased history

USD · from the cash flow

Latest · FY2025
(1.45M) USD
Year-over-year change
—

Common Stock Repurchased vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock repurchased is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Common Stock Repurchased for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$897.54M USD+118.1%+143.6%8.2%
BLCOBausch + Lomb CorporationLTM Jun 2026$27M USD+350.0%—0.5%
STAASTAAR Surgical CompanyLTM Apr 2026$8.49M USD+444.7%—2.9%
GKOSGlaukos CorporationLTM Jun 2026$2.79M USD——0.5%
SGPSpyGlass Pharma, Inc. Common StockFY2025$1.45M USD———
OCSOculis Holding AGLTM Mar 2026CHF 4K CHF——0.8%
SGHTSight Sciences, Inc.LTM Mar 2026$1K USD——0.0%
OCULOcular Therapeutix, Inc.LTM Mar 2026$0 USD——0.0%
RXSTRxSight, Inc.LTM Mar 2026$0 USD——0.0%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$0 USD+100.0%—0.0%
Peer median (excluding SGP) —+234.1%+143.6%0.5%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.